Welcome : Guest

Nippon Chemiphar Co., Ltd. (Japan) - Facts, Figures and Analytical Insights

Abstract

This report presents quick facts about Nippon Chemiphar Co., Ltd., which is principally involved in Pharmaceuticals Business. Illustrated with 97 tables, the report showcases the company's sales performance, key markets and market position as against its competitors operating in the industry.

Code: PCP-10719
Price: $3500
Company Type: Public
Pages: 101
Date: April 2016
Market Data Tables: 97

 NOTE : Select the checkbox below, and click Add to Cart button to add this report to your shopping cart.
Table 1: Nippon Chemiphar Co., Ltd.’s Sales by Business Segment (2013-2014) in Percentage for Pharmaceutical Business and Other Business......5
Drugs......6
Table 2: Drugs Market by Region Worldwide (2014) - Percentage share Breakdown by Value Sales for Switzerland, US, Others Europe, and Rest of World......6
Table 3: Drugs Market by Type Worldwide (2014) - Percentage Share Breakdown by Value Sales for Specialty Drugs, and Traditional Oral Drugs......7
Table 4: Spending on Drugs by Region Worldwide (2014) - Percentage Market Share Breakdown by Value for Canada, European Union, Japan, South Korea, US, and Others......8
Table 5: Drugs Market by Category Worldwide (2015) - Percentage Share Breakdown by Value for Biologics, Monoclonal Antibodies and Other Classes......9
Table 6: Drugs Market by Category Worldwide (2015) - Percentage Share Breakdown by Value for Brand, Generic and Other......10
Table 7: Drugs Market by Technology Worldwide (2015) - Percentage Share Breakdown by Value for Biotechnology, Conventional and Other Unclassified......11
Table 8: Drug Market by Category in Asia-Pacific (2014) - Percentage Share Breakdown by Value Sales for Branded Generics, Originals and Un-Branded Generics......12
Table 9: Drugs Market by Category in Brazil (2015) - Percentage Share Breakdown by Volume for Generics and Others......13
Table 10: Drug Distribution Expenditure by Category in Canada (2015) - Percentage Share Breakdown by Value for Out of Pocket, Private Insurers and Public Payers......14
Table 11: Drugs Market by Type in China (2015) - Percentage Share Breakdown by Value for Medical Devices, Over-the-counter Drugs, Prescription Drugs, Traditional Chinese Medicine, and Others......15
Table 12: Drugs Market by Type in China (2015) - Percentage Share Breakdown by Value for Finished Drugs and Intermediate and Bulk Medicine......16
Table 13: Drugs Market by Category in France (2015) - Percentage Share Breakdown by Value for Generic Drugs, OTC Drugs, and Patented Drugs......17
Table 14: Drugs Market by Sector in Greece (2015) - Percentage Share Breakdown by Value for Generic Drugs, OTC Drugs, and Patented Drugs......18
Table 15: Drugs Market by Category in Italy (2015) - Percentage Share Breakdown by Value for Generic Drugs, OTC Drugs, and Patented Drugs......19
Table 16: Drugs Market by Category in Singapore (2015) - Percentage Share Breakdown by Value for Generic Drugs, OTC Drugs, and Patented Drugs......20
Table 17: Critical Shortage Drugs Market by Category in the US (2015) - Percentage Share Breakdown by Volume for Injectable, Orals, and Others......21
Table 18: Critical Shortage Drugs Market by Segment in the US (2015) - Percentage Share Breakdown by Volume for Anti-Infectives, Central Nervous System (CNS), Oncology, Pain, Vitamins and Minerals, and Others......22
Table 19: Critical Shortage Drugs Market by Type in the US (2015) - Percentage Share Breakdown by Volume for Brand, Branded Generic, Generic, and Other Branded Generic......23
Table 20: Spending on Drugs by Category in the US (2015) - Percentage Share Breakdown by Value for Specialty Drugs and Traditional Drugs......24
Table 21: Drugs Market by Category in the US (2015) - Percentage Share Breakdown by Value for Non-specialty and Specialty......25
Table 22: Drugs Sales by Type in the US (2015) - Percentage Share Breakdown by Value for Cefdinir, Cephalexin, Cofactor and Others......26
Pharmaceuticals......27
Table 23: Pharma Market by Category Worldwide (2015) - Percentage Share Breakdown by Value for Injectables, Oral Solids, Tropicals and Others......27
Table 24: Pharmaceutical Market by Country Worldwide (2015) - Percentage Share Breakdown by Value for China, Japan, USA and Others......28
Table 25: Pharmaceuticals Market by Region Worldwide (2014) - Percentage Share Breakdown by Value Sales for Asia, Africa, and Australasia, European Union, Japan, Latin America, and North America......29
Table 26: Pharmaceuticals Market by Segment Worldwide (2015) - Percentage Share Breakdown by Value for Generic, Originator Brand, and Others......30
Table 27: Pharmaceuticals Sales by Category Worldwide (2014) - Percentage Market Share Breakdown by Value for Active Pharmaceutical Ingredients, Contrast Products, Radiopharmaceuticals, and Specialty Pharmaceuticals......31
Table 28: Pharmaceuticals Market by Category Worldwide (2015) - Percentage Share Breakdown by Value for Biologics and Chemical Synthetic and Others......32
Table 29: Pharmaceutical Consumption by Category in Australia (2014) - Percentage Share Breakdown for Aged over 65 Years, and Aged under 65 Years......33
Table 30: Pharmaceutical Market by Region in Brazil (2015) - Percentage Share Breakdown by Value Sales for Mid-West, North, Northeast, São Paulo, South, and Others......34
Table 31: Pharmaceutical Sales by Category in Brazil (2015) - Percentage Share Breakdown by Value for Generics, Over the Counter (OTC) Drugs, and Prescription......35
Table 32: Pharmaceutical Market by Category in Canada (2015) - Percentage Share Breakdown by Value for Hospital and Retail......36
Table 33: Pharmaceutical Distribution Market by Region in China (2015) - Percentage Share Breakdown by Value for Eastern China, North East China, Northern China, Northwestern China, Southern China, and Southwestern China......37
Table 34: Pharmaceuticals by Therapeutic Area in China (2014) - Percentage Market Share Breakdown by Value Sales for Alimentary & Metabolism, Anti-Infective, Cardiovascular, Central Nervous System, Neoplasm, and Others......38
Table 35: Pharmaceuticals Market by Therapeutic Area in China (2014) - Percentage Share Breakdown by Value Sales for Alimentary Tract and Metabolism, Blood and Blood Forming Organs, Cardiovascular Diseases, Musculo-Skeletal System, Nervous System, Oncology, Respiratory System, Systemic Anti- Infective, and Others......39
Table 36: Pharmaceutical Market by Country in Europe (2014) - Percentage Share Breakdown by Value Sales for France, Germany, Greece, Italy, Spain, UK, and Others......40
Table 37: Pharmaceuticals Market by Region in European Union (2014) - Percentage Share Breakdown by Value Sales for France, Germany, Great Britain, Italy, Spain, and Others......41
Table 38: Pharma Market by Category in Indonesia (2015) - Percentage Share Breakdown by Value for Branded Generics and Licensed, Over the Counter and Unbranded Generics......42
Table 39: Pharmaceutical Market by Region in Latin America (2015) - Percentage Share Breakdown by Value for Argentina, Brazil, Mexico, Venezuela and Others......43
Table 40: Spending on Pharmaceutical by Category in Nigeria (2015) - Percentage Share Breakdown by Value for Generic Drug Sales, Over-The-Counter Medicine Sales and Patented Drug Sales......44
Table 41: Pharmaceuticals Market by Product in the US (2014) - Percentage Share Breakdown by Value Sales for Abilify, AdvairDiskus, Crestor, Cymbalta, Enbrel, Humira, Nexium, Remicade, and Others......45
Table 42: Pharmaceutical Market by Category in Vietnam (2015) - Percentage Share Breakdown by Value for Generic Drugs, Patented Drugs and Others......46
Generic Pharmaceuticals......47
Table 43: Generic Pharmaceuticals Market by Category Worldwide (2014) - Percentage Share Breakdown by Value Sales for Cardiovascular, Central Nervous System (CNS), Dermatology, Diabetes, Hormonal Drugs, Oncology, Respiratory, Rheumatology, and Others......47
Analgesics......48
Table 44: Analgesic Molecules Market by Drug Worldwide (2015) - Percentage Share Breakdown by Value for Aspirin, Ibuprofen, Paracetamol and Others......48
Diabetes Drugs......49
Table 45: Diabetes Drugs Market by Product Category in China (2015) - Percentage Share Breakdown by Value for Acarbose, Insulin, Melbine, and Other Diabetes Drugs......49
Ethical Drugs......50
Table 46: Ethical Drugs Revenues by Category in Indonesia (2015) - Percentage Share Breakdown by Value for Branded Generic, Licensed and Unbranded Generic......50
Gastrointestinal Drugs......51
Table 47: Gastrointestinal Drugs Market by Category Worldwide (2014) - Percentage Share Breakdown by Value Sales for H2 Blockers, Proton Pump Inhibitors, and Others......51
Table 48: Ulcer Drugs by Category in the US (2014) - Percentage Share Breakdown by Number of Prescriptions for H2 Blockers, Proton Pump Inhibitors, and Others......52
IV Generics Drugs......53
Table 49: Global IV Generics Drug Market by Value Sales (2014) - Percentage Share Breakdown for Fresenius Kabi AG, Hospira, Inc., Mylan, Inc., Novartis International AG, Teva Pharmaceutical Industries Ltd., and Others......53
Proton Pump Inhibitors (PPI) Drugs......54
Table 50: Proton Pump Inhibitors (PPI) Drugs Market by Category in the US (2014) - Percentage Market Share Breakdown by Value Sales for Aciphex (JNJ/Eisai), Dexilant (Takeda), Generic Prilosec, Nexium (AZN), Prevacid (Takeda), Prilosec, Protonix (PFE/WYE), and Others......54
Specialty Pulmonary Hypertension Drugs......55
Table 51: Specialty Pulmonary Hypertension Drugs Benefit Market by Category in the US (2015) - Percentage Share Breakdown by Value for Medical Benefit and Pharmacy Benefit......55
Donepezil Tablets......56
Table 52: Donepezil Tablets Market by Brand Name in Brazil (2015) - Percentage Share Breakdown by Value for Pfizer- Eranz, Torrent- Epez and Others......56
Pulmonary Arterial Hypertension (PAH) Treatment Drugs......57
Table 53: Pulmonary Arterial Hypertension (PAH) Treatment by Drug Worldwide (2014) - Percentage Market Share Breakdown by Value Sales for Adcirca, Letairis/Volibris, Remodulin, Revatio, Tracleer, Tyvaso and Ventavis......57
Table 54: Pulmonary Arterial Hypertension (PAH) Treatment by Therapy Worldwide (2014) - Percentage Market Share Breakdown by Value for ERA Monotherapy, PDE-5 Monotherapy and ERA+PDE-5 Combination Therapy......58
Table 55: Pulmonary Arterial Hypertension (PAH) Treatment with Macitentan Drug by Region Worldwide (2014) - Percentage Market Share Breakdown by Value for Japan, US and Rest of World......59
Table 56: Pulmonary Arterial Hypertension (PAH) Treatment with Prostacyclin Therapy by Type Worldwide (2014) - Percentage Market Share Breakdown by Value for Prostacyclin + ERA, Prostacyclin + PDE-5 and Triple Therapy......60
Table 57: Pulmonary Arterial Hypertension (PAH) Treatment by Type Worldwide (2015) - Percentage Breakdown by Value for Inhaled Prostacyclins, Orals (ERAs, PDE5s, Prostacyclins), and Parenteral Prostacyclins......61
Table 58: Pulmonary Arterial Hypertension (PAH) Treatment with Prostacyclin Therapy by Type in Europe (2014) - Percentage Market Share Breakdown by Value for Prostacyclin + ERA, Prostacyclin + PDE-5 and Triple Therapy......62
Table 59: Pulmonary Arterial Hypertension (PAH) Treatment by Therapy in Europe (2014) - Percentage Market Share Breakdown by Value for ERA Monotherapy, PDE-5 Monotherapy and ERA+PDE-5 Combination Therapy......63
Table 60: Pulmonary Arterial Hypertension Treatment Market by Product Segment in Japan (2015) - Percentage Share Breakdown by Value for Adcirca, Dorner, Flolan, Procylin, Revatio, and Tracleer......64
Table 61: Pulmonary Arterial Hypertension (PAH) Treatment by Therapy in the US (2014) - Percentage Market Share Breakdown by Value for ERA Monotherapy, PDE-5 Monotherapy and ERA+PDE-5 Combination Therapy......65
Table 62: Pulmonary Arterial Hypertension (PAH) Treatment with Prostacyclin Therapy by Type in the US (2014) - Percentage Market Share Breakdown by Value for Prostacyclin + ERA, Prostacyclin + PDE-5 and Triple Therapy......66
Pharmaceuticals......67
Table 63: Market Shares of Leading Drug Distributors Worldwide (2014) -Percentage Breakdown by Value for AmerisourceBergen Corporation, Express Scripts, McKesson Corporation, Metro Medical and Others......67
Table 64: Market Shares of Leading Pharmaceutical Companies in Australia (2015) - Percentage Share Breakdown by Value for AstraZeneca, Pfizer, Inc. and Others......68
Table 65: Market Shares of Leading Pharmaceutical Distributors in Brazil (2015) - Percentage Share Breakdown by Value for Panpharma Participacoes S.A., Profarma Distribuidora de Produtos Farmaceuticos S.A., Santa Cruz and Other......69
Table 66: Market Shares of Leading Pharmaceutical Companies in Indonesia (2015) - Percentage Breakdown by Value Sales for Dexa Medica Group, PT Kalbe Farma Tbk., Pfizer Indonesia PT Tbk, Sanbe Farma PT, and Others......70
Table 67: Market Shares of Leading Pharmaceutical Suppliers to Hospitals in Indonesia (2015) - Percentage Breakdown by Value Sales for Dexa Medica Group, PT Kalbe Farma, Tbk, Sanbe Farma PT, Soho Group, and Others......71
Table 68: Market Shares of Leading Pharmaceutical Manufacturers by Value Sales in the US (2014) - Percentage Breakdown for Abbott Laboratories, Amgen Corporation, AstraZeneca Plc, Eli Lilly and Company, F. Hoffmann-La Roche AG, GlaxoSmithKline Plc, Johnson & Johnson, Merck & Co., Inc., Novartis International AG, Pfizer, Inc., Sanofi S.A., Teva Pharmaceutical Industries Ltd., and Others......72
Table 69: Market Shares of Leading Drug Providers in the US (2014) - Percentage Breakdown by Value for Clearwater Paper Corporation and Other Private Label......73
Table 70: Market Shares of Leading Domestic Drugs Manufacturers in Vietnam (2015) - Percentage Share Breakdown by Volume for DHG Pharmaceutical JSC, Traphaco Joint Stock Company and Others......74
Generic Drugs......75
Table 71: Market Shares of Leading Generic Anti-Acne Drug Manufacturers Worldwide (2015) - Percentage Share Breakdown by Value for Mylan, Perrigo Company, Pfizer, Inc., Sandoz and Others......75
Table 72: Market Shares of Leading Generic Injectable Drug Manufacturers Worldwide (2015) - Percentage Breakdown by Volume for Baxter International, Inc., Fresenius SE & Co. KGaA, Hikma Pharmaceuticals Plc, Hospira, Inc., Novartis AG, Pfizer, Inc., Sagent Pharmaceuticals, Inc., Sanofi S.A., and Others......76
Table 73: Market Shares of Leading Branded Generic Pharmaceutical Companies in Brazil (2014) - Percentage Breakdown by Value for Cimed Indústria Farmacêutica Ltda, Ems Sigma Pharma Group, Hypermarcas S.A., Pfizer, Inc., Takeda Pharmaceutical Company Limited, União Química Farmacêutica Nacional S.A and Others......77
Table 74: Market Shares of Leading Generics Pharmaceutical Companies in Brazil (2014) - Percentage Breakdown by Value for Achelois Pharmaceuticals, Inc., Ems Sigma Pharma Group, Eurofarma Laboratórios, Hypermarcas S.A., Pfizer, Inc., Sanofi - Medley Indústria Farmacêutica Ltda and Others......78
Table 75: Market Shares of Leading Generic Pharmaceutical Companies by Value Sales in India (2014) - Percentage Breakdown for Abbott India Ltd., Alkem Laboratories Ltd., Cipla Ltd., GlaxoSmithKline Pharmaceuticals Ltd. (GSK), Lupin Ltd., Mankind Pharma, Pfizer Ltd., Ranbaxy Laboratories Ltd., Sun Pharmaceutical Industries Ltd., Zydus Cadila and Others......79
Table 76: Market Shares of Leading Generic Injectable Drug Manufacturers in the US (2015) - Percentage Share Breakdown by Value for Baxter International, Inc., Fresenius, Hospira, Inc., Novartis (Sandoz), and Others......80
Table 77: Market Shares of Leading IV Generic Drugs Manufacturers by Value Sales in the US (2014) - Percentage Breakdown for Baxter International, Inc., Fresenius Kabi AG, Hospira, Inc., Novartis International AG, Sun Pharmaceutical Industries Limited and Others......81
Amlodipine Besylate Tablets......82
Table 78: Market Shares of Leading Amlodipine Besylate Tablet Manufacturers for Antihypertensive Therapy Worldwide (2015) - Percentage Share Breakdown by Hospital Sales for Pfizer, Inc., Saike Pharmaceutical Co., Ltd., Yangtze River Pharmaceutical Group, and Others......82
Analgesics......83
Table 79: Market Shares of Leading Analgesics Manufacturers by Value Sales Worldwide (2014) - Percentage Breakdown for Johnson & Johnson, Pfizer, Inc., Reckitt Benckiser Plc, and Others......83
Table 80: Market Shares of Leading Anaesthetics & Analgesics Product Manufacturers Worldwide (2015) - Percentage Breakdown by Value for Fresenius SE & Co., and Others......84
Table 81: Market Shares of Leading Analgesics Manufacturers in Africa Middle East (2015) - Percentage Share Breakdown by Value for GlaxoSmithKline, Johnson & Johnson, Reckitt Benckiser Group and Others......85
Table 82: Market Shares of Leading Analgesics Manufacturers in Asia-Pacific (2015) - Percentage Share Breakdown by Value for GlaxoSmithKline, Johnson & Johnson, Reckitt Benckiser Group and Others......86
Table 83: Market Shares of Leading Drug (Analgesics Capsule) Companies in China (2015) - Percentage Breakdown by Value for Beijing Novartis Pharma Ltd., GlaxoSmithKline (Tianjin) Co., Ltd., Tibet Cheezheng Tibetan Medicine Company Ltd., Yunnan Baiyao Group, and Others......87
Table 84: Market Shares of Leading Analgesics Manufacturers in Europe (2015) - Percentage Share Breakdown by Value for GlaxoSmithKline, Johnson & Johnson, Reckitt Benckiser Group and Others......88
Table 85: Market Shares of Leading Analgesic Product Manufacturers in India (2015) - Percentage Share Breakdown by Value for Emami Ltd., Glaxo SmithKline Consumer Healthcare Ltd., Reckitt Benckiser Group Plc, and Others......89
Table 86: Market Shares of Leading Analgesic Products Brands in India (2015) - Percentage Share Breakdown by Value for Zandu Balm & Mentha Balm, and Others......90
Table 87: Market Shares of Leading Analgesics Brands in Indonesia (2015) - Percentage Share Breakdown by Value for Bodrex (regular), Oskadon, Paramex, Puyer 16 and Others......91
Table 88: Market Shares of Leading Analgesics Brands in Indonesia (2015) - Percentage Share Breakdown by Volume for Bodrex (regular), Oskadon, Paramex, Puyer 16 and Others......92
Table 89: Market Shares of Leading Analgesics Manufacturers in Latin America (2015) - Percentage Share Breakdown by Value for GlaxoSmithKline, Johnson & Johnson and Others......93
Table 90: Market Shares of Leading Analgesic Brands in Nigeria (2015) - Percentage Breakdown by Value for Alabukun, Emzor, Pandol, and Others......94
Table 91: Market Shares of Leading Analgesics Manufacturers in North America (2015) - Percentage Share Breakdown by Value for GlaxoSmithKline, Johnson & Johnson and Others......95
Table 92: Market Shares of Leading Analgesic (Internal Tablet) Manufacturers by Value Sales at Drug Stores, Food Stores, Mass Merchandisers (including Wal-Mart) in the US (2015) - Percentage Breakdown for Bayer Consumer Health Division, McNeil Consumer Products, Pfizer, Inc., Private Label, and Others......96
Alzheimer Disease Therapeutics......97
Table 93: Market Shares of Leading Alzheimer Disease Therapeutic Providers by Value Sales Worldwide (2014) - Percentage Breakdown for Forest Laboratories, Inc., Johnson & Johnson, Novartis International AG, Pfizer, Inc., and Others......97
Table 94: Market Shares of Leading Therapeutic Providers (Alzheimer's Disease, Bone Diseases, Cardiology, CNS, Dermatology, Diabetes/Metabolic, Epilepsy, G.I./Ulcer, HBV/HCV, Infectious Disease, Multiple Sclerosis, Obesity, Onc./Hematology, Ophthalmology, Orphan Disease, Pain Management, Respiratory, Rheumatology, Sleep Disorders, Urinary Incont., and Women's Health) by Value Sales Worldwide (2014) - Percentage Breakdown for AbbVie, Amgen, Inc., AstraZeneca Plc, Biogen Idec, Inc., Bristol-Myers Squibb Company, Eli Lilly and Company, Endo International Plc, F. Hoffmann-La Roche AG, Forest Laboratories, Inc., GlaxoSmithKline Plc, Johnson & Johnson, Merck Ltd., Novartis AG, Novo Nordisk A/S, Pfizer, Inc., Sanofi S.A., and Others......98
Diabetes Drugs......99
Table 95: Market Shares of Leading Diabetes Care Companies Worldwide (2014) - Percentage Breakdown by Value Sales for Bristol-Myers Squibb (Incl Amylin), Eli Lilly and Company, Merck & Co., Inc., Novo Nordisk A/S, Sanofi S.A. and Others......99
Table 96: Market Shares of Leading Diabetes Drugs Manufacturers by Value Sales Worldwide (2014) - Percentage Breakdown for AstraZeneca Plc, Bristol-Myers Squibb Company, Eli Lilly and Company, GlaxoSmithKline Plc, Johnson & Johnson, Merck Ltd., Novartis AG, Novo Nordisk A/S, Pfizer, Inc., Sanofi S.A., and Others......100
Table 97: Nippon Chemiphar Co., Ltd.'s Sales by Business Segment Worldwide (2013) in Percentage for Pharmaceutical Products and Other Business......101